Follow
Majid Zeidi,MD
Title
Cited by
Cited by
Year
Itch in dermatomyositis: the role of increased skin interleukin‐31
HJ Kim, M Zeidi, D Bonciani, SM Pena, J Tiao, S Sahu, VP Werth
British Journal of Dermatology 179 (3), 669-678, 2018
632018
Selective immunoglobulin A deficiency in Iranian blood donors: prevalence, laboratory and clinical findings
S Shiva, P Zahra, A Asghar, PA Akbar, S Azam, F Maryam, A Zohreh, ...
Iranian Journal of Allergy, Asthma and Immunology, 157-162, 2008
362008
Hepatitis B viral DNA among HBs antigen negative healthy blood donors
M Vaezjalali, S Rashidpour, H Rezaee, B Hajibeigi, M Zeidi, L Gachkar, ...
Hepatitis monthly 13 (3), 2013
352013
Cannabinoid reduces inflammatory cytokines tumor necrosis factor alpha and type I interferons in dermatomyositis in vitro
ES Robinson, P Alves, MM Bashir, M Zeidi, R Feng, VP Werth
The Journal of investigative dermatology 137 (11), 2445, 2017
302017
Increased myeloid dendritic cells and TNF-α expression predicts poor response to hydroxychloroquine in cutaneous lupus erythematosus
M Zeidi, HJ Kim, VP Werth
Journal of Investigative Dermatology 139 (2), 324-332, 2019
262019
Quinacrine suppresses tumor necrosis factor-α and IFN-α in dermatomyositis and cutaneous lupus erythematosus
P Alves, MM Bashir, M Wysocka, M Zeidi, R Feng, VP Werth
Journal of Investigative Dermatology Symposium Proceedings 18 (2), S57-S63, 2017
242017
Sebaceous induction in dermatofibroma: a common feature of dermatofibromas on the shoulder
M Zeidi, JP North
Journal of Cutaneous Pathology 42 (6), 400-405, 2015
142015
The study of total IgE reference range in healthy adults in Tehran, Iran
RS Shoormasti, Z Pourpak, MR Eshraghian, MTH Ashtiani, M Jamali, ...
Iranian Journal of Public Health 39 (3), 32, 2010
142010
Determination of lymphocyte subsets reference values in healthy Iranian men by a single platform flow cytometric method
AA Alamooti, FA Ardalan, A Abdolahi, M Zeidi, F Firouzjaie
Cytometry Part A 77 (9), 890-894, 2010
112010
The effects of immunostimulatory herbal supplements on autoimmune skin diseases
CE Bax, S Chakka, JSS Concha, M Zeidi, VP Werth
Journal of the American Academy of Dermatology 84 (4), 1051-1058, 2021
92021
Recent advances in pharmacological treatments of adult dermatomyositis
KL Chen, M Zeidi, VP Werth
Current Rheumatology Reports 21 (10), 1-10, 2019
92019
Polymorphisms and serum level of mannose-binding lectin: An Iranian survey
A Soltani, S RahmatiRad, Z Pourpak, Z Alizadeh, S Saghafi, B HajiBeigi, ...
Iranian Journal of Allergy, Asthma and Immunology, 428-432, 2014
92014
Myeloid Dendritic Cells Are Major Producers of IFN-β in Dermatomyositis and May Contribute to Hydroxychloroquine Refractoriness
KL Chen, J Patel, M Zeidi, M Wysocka, MM Bashir, B Patel, S Maddukuri, ...
Journal of Investigative Dermatology 141 (8), 1906-1914. e2, 2021
82021
Fri0307 lenabasum, a cannabinoid type 2 receptor agonist, reduces cd4 cell populations and downregulates type 1 and 2 interferon activities in lesional dermatomyositis skin
K Chen, M Zeidi, N Reddy, B White, V Werth
Annals of the Rheumatic Diseases 78 (Suppl 2), 835-835, 2019
72019
Acute onset/flares of dermatomyositis following ingestion of IsaLean® herbal supplement: clinical and immunostimulatory findings
M Zeidi, PB Chansky, VP Werth
Journal of the American Academy of Dermatology 80 (3), 801-804, 2019
72019
Increased MxA protein expression and dendritic cells in spongiotic dermatitis differentiates dermatomyositis from eczema in a single center case-control study
M Zeidi, KL Chen, B Patel, A Ravishankar, R Lim, VP Werth
Journal of Cutaneous Pathology, 2020
42020
Lenabasum, a Cannabinoid Type 2 Receptor Agonist, Reduces T-Cell Population and Downregulates Type 1 and 2 Interferon Activities in Lesional Dermatomyositis Skin
N Reddy, M Zeidi, B White, VP Werth
Arthritis & Rheumatology 70 (S9), 3356-3357, 2018
42018
Increased tissue-resident memory T (T-RM) cells and STAT3 expression in cutaneous lupus erythematosus patients refractory to antimalarials
M Zeidi, K Desai, KL Chen, H Kim, RK Lim, VP Werth
Journal of Investigative Dermatology 139 (5), S174, 2019
32019
Cannabinoid type 2 receptor (CB2R) distribution in dermatomyositis skin and peripheral blood mononuclear cells (PBMCs) and in vivo effects of LenabasumTM
S Maddukuri, J Patel, DA Diaz, KL Chen, M Wysocka, C Bax, Y Li, ...
Arthritis research & therapy 24 (1), 1-11, 2022
22022
Plasma-derived Extracellular Vesicles Induced STING-mediated Proinflammatory Effects in Dermatomyositis
Y Li, C Bax, J Patel, A Ravishankar, K Desai, M Zeidi, M Bashir, V Werth
ARTHRITIS & RHEUMATOLOGY 72, 2020
22020
The system can't perform the operation now. Try again later.
Articles 1–20